Burosumab
Product Specifications
CAS Number
1610833-03-8
Target
Others
Related Pathways
Others
Purity
0.984
Bioactivity
Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
B2553-52A-ML550 100 µL
BMP15, ID (Bone Morphogenetic Protein 15, BMP-15, Growth/Differentiation Factor 9B, GDF-9B, GDF9B) (MaxLight 550) discontinued
Sign In for Pricing
View Details